CJC-1295: Clinical Use and Prescribing
Tracking # 20-1402839
$79.00
There are no ratings for this course
Learn moreCourse overview
This continuing education course reviews the pharmacology, evidence, safety and regulatory status of CJC-1295. Content covers its effects on growth hormone and IGF-1 signaling, available human research, contraindications, adverse effects, laboratory assessment and patient counseling. Participants will learn how to respond when patients request or report using CJC-1295 and how to document evidence-based clinical decisions.
Subject areas
This course counts toward the state boards and subject areas below.
Florida Board of Nursing
Advanced Practice Registered Nurse
Licensed Practical Nurse
Registered Nurse
Disclosure statements
Dr. Stephen Petteruti and the course planners report no relevant financial relationships with commercial interests related to this educational activity. No commercial support was received for the development of this course.
This course discusses the off-label and investigational use of peptides in adults, including compounded formulations. Some peptides presented are not FDA-approved for clinical use or are used outside their FDA-approved indications. Any off-label or investigational use will be identified throughout the course.
The content is provided for continuing professional education. Participants remain responsible for applying independent clinical judgment, practicing within their professional scope and following applicable federal and state prescribing, compounding and documentation requirements. References to laboratories, pharmacies, products or brand names are for educational identification and do not represent endorsement.